Moderna receives full approval for COVID-19 vaccine by U.S. FDA
The U.S. Food and Drug Administration (FDA) approved the Biologics License Application (BLA) for SPIKEVAX (COVID-19 Vaccine, mRNA) to prevent COVID-19 in individuals 18 years of age and older in the U.S.
Press releases
The Egyptian Alliance for Vaccine Manufacturers: A New Step Towards Achieving Self-Sufficiency and Strengthening National Health Security
At Gennvax, we are thrilled to announce a significant milestone in our journey to support Egypt’s vision of localizing vaccine production. In collaboration with the
December 3, 2024
